Home Daily Chart

Daily Chart

The Daily Chart Newsletter is available only to members of this site. Register now for FREE. No cost, no obligation, join today.

Two of the Hottest Trades Investors Should Not Overlook

Talk about great timing. Just the other day, we recommended buy Canopy Growth (CGC) and Tilray Inc. (TRLY), as analysts became increasingly bullish on the...

Why it’s Time to Buy Cannabis Stocks Again

Controversial or not, cannabis could be one of the most rewarding trades of the year. According to analysts at Cowen, U.S. cannabis sales alone could...

This May be the Hottest Trump Trade of 2019

Keep an eye on steel stocks. Over the weekend, President Trump noted the border wall could be made of steel instead of concrete in an...

Traders Daily – The 2019 Dogs of the Dow

Barron’s once reported that the “Dogs of Dow Investing Strategy no Longer Works.” Others have argued that it’s no longer a successful trading theory. But they...

Traders Daily – The 3 Top Stocks to Own Now

After one of the most bizarre, aggravating years on record for the markets, a great deal of top stocks fell too much too fast,...

Traders Daily: Two Hot IPOs to Keep on Radar in 2019

2019 is shaping up to be another great year for IPOs. Uber. Lyft, and Palantir are just three of the hottest ones making headlines.  But...

Three of the Most Oversold Opportunities to Consider

After weeks of intense market volatility, the Dow Jones exploded more than 1,000 points, as stocks just begin to recover from a Christmas Eve...

How to Profit from 3 of the Hottest IPOs in 2019

2018 was quite a year for IPOs. In fact, there were 188 of them, raising up to $45.7 billion.  By the way, that’s about 47%...

Traders Daily – Johnson & Johnson (JNJ) Begins to Bounce

Perhaps the bad news has now been priced into shares of Johnson & Johnson (JNJ). As we noted yesterday: According to Johnson & Johnson, the Reuters...

Traders Daily – There May be Opportunity in Johnson & Johnson

There may soon be opportunity in oversold shares of Johnson & Johnson (JNJ). According to Johnson & Johnson, the Reuters article is “one-sided and inflammatory.” “Johnson...

Stay connected

0FansLike
3FollowersFollow
0SubscribersSubscribe
- Advertisement -